Allscripts Healthcare Solutions Inc is primarily active in the healthcare industry.

The main competitors of Allscripts Healthcare Solutions Inc in the market include Cerner Corporation, Epic Systems Corporation, and Meditech.

Allscripts Healthcare Solutions Inc is a leading healthcare information technology company established in 1986. The company features a rich history and background, having grown from a small startup to a global provider of electronic health records (EHR), practice management systems, and population health management solutions. Allscripts is dedicated to enhancing patient care by empowering healthcare organizations with innovative technology. With a strong presence in the healthcare industry, Allscripts serves over 180,000 physicians and more than 2,500 hospitals worldwide. Continuously evolving and expanding its offerings, Allscripts Healthcare Solutions Inc remains at the forefront of the digital healthcare revolution.

Allscripts Healthcare Solutions Inc has achieved several significant milestones in its history. The company has successfully launched innovative products, expanded its market share, and entered into strategic partnerships within the healthcare industry. Allscripts Healthcare Solutions Inc has also received industry recognition for its excellent performance and dedication to providing high-quality healthcare solutions. By continuously investing in research and development, the company has consistently improved its technology offerings, contributing to the overall advancement of healthcare services. With its commitment to excellence, Allscripts Healthcare Solutions Inc continues to shape the future of healthcare with its groundbreaking solutions and services.

Allscripts Healthcare Solutions Inc is primarily present in the United States of America.

Allscripts Healthcare Solutions Inc represents the values of innovation, collaboration, and patient-centered care. With a commitment to improving healthcare technology, Allscripts aims to transform the way healthcare is delivered and experienced. The company values a collaborative approach, working closely with healthcare providers and patients to develop solutions that enhance clinical outcomes and patient satisfaction. Allscripts prioritizes the use of advanced technology and data analytics to drive better healthcare decision-making and deliver personalized care. Through its comprehensive suite of software and services, Allscripts aims to empower healthcare organizations to deliver efficient, high-quality care to their patients.

Analysts currently set an average price target of 4,93 USD for the Veradigm stock (median: 5,10 USD), implying -0,4 % versus the latest price. The consensus is based on 10 analyst ratings.

Veradigm Prezzi Obiettivo Analisti 2026

10 analysts currently rate the Veradigm stock: 6 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Veradigm to generate revenue of 583,20 Mio. USD and earnings per share of 0,25 USD.

Veradigm Prezzi Obiettivo Analisti 2026

Converted at the current exchange rate, the Veradigm share trades at 4,28 EUR (4,95 USD).

The Veradigm share (MDRX) is listed on 4 stock exchanges, including: NASDAQ (MDRX), Frankfurt (AL21.F), München (AL21.MU), Düsseldorf (AL21.DU).

Allscripts Healthcare Solutions Inc is an American company specializing in providing IT solutions for healthcare providers. The company was founded in 1986 as a small software firm in Chicago and has since become one of the leading providers of electronic health records and other health IT solutions. Allscripts offers a wide range of products and services to meet the needs of healthcare providers of all sizes and types. The various business areas of Allscripts include hospitals and health systems, physician practices, accountable care organizations (ACOs), and pharmacies. Allscripts' products and services are designed to increase the efficiency of healthcare providers, improve the quality of patient care, and meet the growing demand for connected healthcare. In the hospital and health systems area, Allscripts offers a comprehensive portfolio of solutions to meet the complex requirements of large and complex health systems. This includes electronic health records, laboratory and imaging management, portfolio management, revenue cycle management, and reporting. In the physician practices area, Allscripts provides a variety of solutions to increase the efficiency of individual practices and smaller group practices. Products in this area include electronic health records, appointment scheduling, billing, prescription management, and patient portals. For ACOs, Allscripts offers a variety of solutions to support the community of healthcare facilities and providers. This includes solutions for collaboration management, population health management, and the automation of clinical workflows. Allscripts' solutions are also of interest to pharmacies. Allscripts offers solutions for optimizing inventory management, billing, and patient care. The company relies on state-of-the-art IT solutions and implements industry-leading methods for data analysis. Allscripts employs over 8,600 employees and has customers in over 190 countries. The company demonstrates its commitment to innovation in the healthcare industry through the development of new products and services. For example, a program to enhance the functionality of implanted pacemakers was recently introduced, which can be operated directly from a smartphone via a secure cloud system. With the introduction of new products and solutions, Allscripts aims to further expand its business in the healthcare sector and strengthen its position as a leading provider of health IT solutions. In summary, Allscripts Healthcare Solutions Inc is a leading provider of health IT solutions that offers a wide range of products and services for healthcare providers of all sizes and types. Allscripts aims to make healthcare more sustainable, digital, and connected, and to increase the efficiency of the healthcare system through innovative solutions.

Il attesa fatturato di Veradigm ammonta a 583,20 Mio. USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.

Il attesa profitto di Veradigm ammonta a 32,67 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.

Il rapporto prezzo/utili (P/E) di Veradigm è attualmente 19,53. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Veradigm.

Il rapporto prezzo/fatturato (P/S) di Veradigm è attualmente 1,09. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Veradigm.

Il Quality Score AlleAktien per Veradigm è 1/10.

L'ISIN di Veradigm è US01988P1084. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.

Il WKN di Veradigm è 607917. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.

Il ticker di Veradigm è MDRX. Con questo simbolo di borsa vengono negoziate le azioni Veradigm in borsa.

Veradigm ha pagato dividendi ogni anno negli ultimi 0 anni.

Veradigm è assegnato al settore 'Sanità'.

I dividendi di Veradigm sono distribuiti in USD.